|
Q2 FY2026
As of Jun 30, 2026
|
Q1 FY2026
As of Mar 31, 2026
|
Q4 FY2025
As of Dec 31, 2025
|
Q3 FY2025
As of Sep 30, 2025
|
Q2 FY2025
As of Jun 30, 2025
|
Q1 FY2025
As of Mar 31, 2025
|
Q4 FY2024
As of Dec 31, 2024
|
Q3 FY2024
As of Oct 15, 2024
|
|
|---|---|---|---|---|---|---|---|---|
| Current assets: | ||||||||
| Cash | ||||||||
| Prepaid expense | ||||||||
| Total Current Assets | ||||||||
| Investment held in Trust Account | ||||||||
| TOTAL ASSETS | ||||||||
| Current liabilities: | ||||||||
| Accrued liabilities | ||||||||
| Promissory note – related party | ||||||||
| Related Party | ||||||||
| Total promissory note – related party | ||||||||
| Due to related party | ||||||||
| Total Current Liabilities | ||||||||
| Deferred underwriting compensation | ||||||||
| TOTAL LIABILITIES | ||||||||
| Ordinary shares subject to possible redemption, 1,685,982 and 4,201,655 shares issued and outstanding at redemption value of $10.90 and $10.56 as of June 30, 2026 and December 31, 2025, respectively | ||||||||
| Shareholders’ Deficit: | ||||||||
| Ordinary shares, $0.0001 par value; 55,000,000 shares authorized; 1,749,375 shares issued and outstanding as of June 30, 2026 and December 31, 2025 (excluding 1,685,982 and 4,201,655 shares subject to possible redemption), respectively | ||||||||
| Accumulated deficit | ||||||||
| Total Shareholders’ Deficit | ||||||||
| TOTAL LIABILITIES, TEMPORARY EQUITY AND SHAREHOLDERS’ DEFICIT |
Loading...
